PremiumCompany AnnouncementsImmuron Limited Announces New Share Issuance Immuron Limited Announces Cessation of Performance Rights Immuron Limited Announces New Securities Issuance PremiumCompany AnnouncementsImmuron Limited Highlights Innovative Infectious Disease Treatments at Conference Immuron reports strong sales growth of Travelan Immuron Limited Issues New Ordinary Shares Complying with Legal Standards PremiumCompany AnnouncementsImmuron Partners with Monash University to Combat Antimicrobial Resistance Immuron announces Travelan clinical trial update Immuron Submits Positive Travelan® Phase 2 Study Results to FDA